Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

C3DC Malonyl (Malonylcarnitine)

Immunology & Autoimmune

C3DCC3-DC (Malonylcarnitine)Malonylcarnitine

Review status

Currently under review

Pending specialist review and validation.

What it shows

This test measures malonylcarnitine, also called C3DC, in your blood. Malonylcarnitine is an acylcarnitine formed when malonyl groups are attached to carnitine. It reflects how your body handles certain steps in fatty acid and energy metabolism that involve malonyl‑CoA and the enzyme malonyl‑CoA decarboxylase.

Clinicians use this measurement as part of an acylcarnitine profile to look for inherited metabolic conditions, including malonyl‑CoA decarboxylase deficiency, sometimes called malonic acidemia. The test is commonly performed in infants and children, and may also be used to monitor people with known metabolic disorders.

The sample is usually a small amount of blood analyzed by tandem mass spectrometry, a highly sensitive method that can detect many acylcarnitines at once.

Why it matters

Malonylcarnitine can be higher than expected when the body cannot properly break down or recycle malonyl‑CoA. Persistently increased levels may point to a rare inherited condition that can affect the heart, muscles, and energy balance. Identifying this pattern helps your care team decide on next steps, such as additional lab tests or genetic evaluations.

Doctors may order this test when a newborn screen suggests a possible metabolic disorder, when a child has symptoms like poor feeding, low energy, or heart problems, or to follow up on known diagnoses. It can also help monitor response to nutrition changes or treatments that aim to support energy metabolism.

Understanding your results

Your results are interpreted in the context of age and clinical situation. A single borderline or unexpected result is often rechecked, because values can shift in the first weeks of life or during illness. If your level is higher than expected on repeat testing, your clinician may order confirmatory studies such as urine organic acids, a broader acylcarnitine profile, enzyme studies, or genetic testing.

Lower or undetectable values are usually not concerning by themselves. If your result does not match how you or your child is feeling, your clinician will consider timing of the sample, nutrition, medicines, and other lab findings. Always discuss next steps with your care team, who can guide monitoring, diet adjustments, or referral to a metabolic specialist when needed.

Reference ranges

00.12 umol/L
All sexes
0 days – 7 days
00.09 umol/L
All sexes
7 days – 1 month
00.1 umol/L
All sexes
1 month – 12 months
00.1 umol/L
All sexes
12 months – 13 years
00.13 umol/L
All sexes
13 years – 19 years
00.1 umol/L
All sexes
19 years – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact C3DC Malonyl (Malonylcarnitine)

  • Age and timing after birth

    Acylcarnitine patterns change in the first days and weeks of life as feeding starts and metabolism adapts. Newborns may need repeat testing to confirm a stable result.

  • Illness or fasting

    Fever, infections, poor intake, or catabolic stress can alter acylcarnitine levels and may temporarily raise or change malonylcarnitine patterns.

  • Nutrition and supplements

    Parenteral nutrition, specialized formulas, and carnitine or fatty acid supplements can influence acylcarnitine profiles, so tell your clinician what you or your child is receiving.

  • Sample handling

    Improper drying, delayed processing, or storage issues can affect tandem mass spectrometry measurements. Proper collection and transport reduce the chance of misleading results.

  • Medications

    Some drugs that affect fatty acid synthesis or mitochondrial function can shift acylcarnitine levels. Provide a complete medication list, including over‑the‑counter products.

  • Underlying metabolic or renal conditions

    Other inborn errors of metabolism or reduced kidney function can modify acylcarnitine concentrations, which may complicate interpretation and require specialist input.

2026

References

  1. McGill University Health Centre. (2018, December 03). C3DC Malonyl (Task CD 2064192). Laboratory reference ranges.
  2. McGill University Health Centre. (2019, May 21). C3DC Malonyl (Task CD 2064192). Laboratory reference ranges.
  3. McGill University Health Centre. (2019, June 07). C3DC Malonyl (Task CD 2064192). Laboratory reference ranges.
  4. Clinical and Laboratory Standards Institute. (2010). Newborn screening by tandem mass spectrometry; Approved guideline (CLSI document NBS04-A). Wayne, PA: CLSI.
  5. University of Washington, Seattle. (2020). Malonyl‑CoA Decarboxylase Deficiency. In GeneReviews. Seattle, WA: University of Washington.